Activation of autoreactive lymphocytes in the lung by radioresistant cells expressing a STING gain-of-function mutation
JCI Insight · 2024
DOI: 10.1172/jci.insight.174331 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2024. Verfasst von Kevin MingJie Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Innate Immunity and. Hauptthemen laut MEDLINE: Gain of Function Mutation, Membrane Proteins, Lymphocyte Activation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Gain-of-function mutations in the dsDNA sensing adaptor STING lead to a severe autoinflammatory syndrome known as STING-associated vasculopathy with onset in infancy (SAVI). Patients with SAVI develop interstitial lung disease (ILD) and produce autoantibodies that are commonly associated with systemic autoimmune diseases. Mice expressing the most common SAVI mutation, STING V154M (VM), similarly develop ILD but exhibit severe T and B cell lymphopenia and low serum Ig titers, and they lack autoantibodies. Importantly, lethally irradiated VM hosts reconstituted with WT stem cells (WT→VM) still develop ILD. In this study, we find that WT→VM chimeras had restored B cell function, produced autoantibodies, and thereby recapitulated the loss of tolerance seen in patients with SAVI. Lymphocytes derived from both WT and BCR or TCR transgenic (Tg) donors accumulated in the extravascular lung tissue of WT+Tg→VM mixed chimeras, but lymphocyte activation and germinal center formation required WT cells with a diverse repertoire. Furthermore, when T cells isolated from the WT→VM chimeras were adoptively transferred to naive Rag1-deficient secondary hosts, they trafficked to the lung and recruited neutrophils. Overall, these findings indicated that VM expression by radioresistant cells promoted the activation of autoreactive B cells and T cells that then differentiated into potentially pathogenic effector subsets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Innate Immunity and.
- Division of Rheumatology, Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts, USA.
- Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California, USA.
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
- NIAID
- Lupus Research Alliance
- NHLBI
- NIGMS
- Henry Gustav Floren Trust
Zitieren
APA
Gao, K. M., Chiang, K., Subramanian, S., Yin, X., Utz, P. J., Nündel, K., Fitzgerald, K. A., & Marshak-Rothstein, A. (2024). Activation of autoreactive lymphocytes in the lung by radioresistant cells expressing a STING gain-of-function mutation. JCI Insight. https://doi.org/10.1172/jci.insight.174331
Vancouver
Gao KM, Chiang K, Subramanian S, Yin X, Utz PJ, Nündel K, et al. Activation of autoreactive lymphocytes in the lung by radioresistant cells expressing a STING gain-of-function mutation. JCI Insight. 2024. doi:10.1172/jci.insight.174331
BibTeX
@article{Gao2024,
author = {Gao, Kevin MingJie and Chiang, Kristy and Subramanian, Sharon and Yin, Xihui and Utz, Paul J and Nündel, Kerstin and Fitzgerald, Kate A and Marshak-Rothstein, Ann},
title = {Activation of autoreactive lymphocytes in the lung by radioresistant cells expressing a STING gain-of-function mutation},
journal = {JCI Insight},
year = {2024},
doi = {10.1172/jci.insight.174331}
}
EUVIMED